Antimicrobial Focus Ltd. Offers Support and Consultancy for Biotech and Pharma Companies Developing New Antimicrobial Agents.
Based on >30 years R&D experience in academia and CROs that includes the following continuum of molecules (non-confidential data only):
Dr. Ian Morrissey, BSc, MBA, PhD, FRSM
Founder, Antimicrobial Focus Ltd.
Well acquainted with the microbiology and susceptibility testing requirements for new antimicrobial agents.
Member and Advisor to the Veterinary Antimicrobial Susceptibility Testing Sub-committee of the Clinical Laboratory Standards Institute (USA).
GARDP REVIVE Contributing Expert.
Sole or co-author of more than 400 publications/presentations on antimicrobial action and resistance.
Previous drug-development-related positions:
Chief Scientific & Development Officer, IHMA Europe, Switzerland.
Director of Microbiology, Quotient Bioresearch Ltd., UK.
Chief Executive Officer, G.R. Micro Ltd., UK.
Microbiology Support & Consultancy
New agent development plans Due diligence Veterinary antimicrobial safety studies Antimicrobial agent susceptibility testing methodology (eg. CLSI & EUCAST) Data analysis Report and manuscript writing